This page is intended for physicians and nurse practitioners who are registered in the POATSP education and training pathway to prescribe opioid agonist treatment (OAT) medications.

For registered nurses (RNs) or registered psychiatric nurses (RPNs) authorized to prescribe OAT medications, information about the RN and RPN education and training pathway is here.

The education and training pathway

There are three components to the education and training pathway for prescribing OAT medications (the POATSP Online Course, workbook, preceptorship)

Education and training pathway streams

The education and training pathways are tailored according to the OAT medication and setting:

  • Buprenorphine/naloxone only
  • All oral OAT in community settings
  • All oral OAT in acute care settings
  • Injectable OAT

Note: Physicians and nurse practitioners are not required to complete the education and training pathway in order to prescribe buprenorphine/naloxone for opioid use disorder. However, physicians and nurse practitioners are strongly encouraged to take the POATSP Online Course to learn the latest evidence-based guidance for prescribing this medication and for more information about induction protocols.

The education and training pathway: step-by-step guide

  1. Complete the required modules in the POATSP Online Course
  2. Obtain a Certificate of Completion in the online platform
    • Upon obtaining this certificate, the following information is provided:
      • A list of approved preceptors
      • Where to access the workbooks
  3. Select an approved preceptor
  4. Contact the preceptor to schedule a preceptorship
    • Note that the preceptorship must be with a preceptor approved by the BCCSU
  5. Complete the appropriate workbook either on paper or electronically
  6. Bring the completed workbook to the preceptorship
  7. Attend the in-person preceptorship
    • Reminder: Complete the Preceptorship Form before attending the preceptorship, as outlined in step 5
  8. Complete any additional learning at the discretion of the preceptor
    • If adding more than one additional preceptorship day, please discuss with the BCCSU by emailing [email protected]
  9. Sign the Safe Prescribing Agreement (found in the workbook) with the preceptor
  10. Complete the online Preceptorship Form (found in the workbook)
    • The Preceptorship Form is an online form to report that the preceptorship has been scheduled

Once these steps above are completed, the preceptor will need to:

  • Complete Preceptor Review Form (sent to the preceptor via email) and submit to the BCCSU

After the education and training pathway has been completed

For oral OAT education and training pathways

  • The BCCSU will issue a Proof of Completion letter, which is sent via email to both:
    • The prescriber
    • The College of Physicians and Surgeons of BC (physicians only)

After obtaining the Proof of Completion letter, prescribers may continue prescribing OAT medications in perpetuity as the letter does not expire (excluding direct follow up or disciplinary action from the relevant College).


For the iOAT education and training pathway

  • The BCCSU will then send the preceptee the Collaborative Prescribing Agreement: Hydromorphone 50mg/mL Injection for Opioid Agonist Treatment (CPA)
  • The preceptee will then:
    • Complete and sign the CPA
    • Return to the BCCSU for signatures
  • The BCCSU will:
    • Authorize
    • Send the CPA to the Ministry of Health for PharmaNet activation
  • Once this process is completed, the BCCSU will send a fully executed copy and confirmation email to the applicant

Return the completed CPA to BCCSU

The completed CPA must be returned to the BCCSU ([email protected]).

Returning this document elsewhere will cause a delay in iOAT prescribing, where iOAT medications will remain inactivated in PharmaNet. Prescriptions for iOAT will not be dispensed until this form is returned to the BCCSU.

Renewal process and continuing education

There are no further educational or administrative requirements for OAT prescribing; however, as with all medical care, prescribers are expected to continue their medical education and stay up to date on best practices and clinical guidelines.

The BCCSU will send all trained prescribers who opt-in a monthly Addiction Care Provider Blast featuring systems-level changes relevant to prescribers in BC and updated clinical guidance from the BCCSU.

BC Centre on Substance Use

400-1045 Howe St, Vancouver, BC V6Z 2A9

E: [email protected] | T: (778) 945-7616 | F: (604) 428-5183

24/7 Addiction Clinician Support Line: (778) 945-7619

Online Addiction Medicine Diploma: [email protected].

website logos footer

Copyright © 2023, BC Centre on Substance Use